Jacobs Levy Equity Management Inc. Trims Stock Position in ZimVie Inc. (NASDAQ:ZIMV)

Jacobs Levy Equity Management Inc. reduced its stake in ZimVie Inc. (NASDAQ:ZIMV) by 14.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 320,012 shares of the company’s stock after selling 53,269 shares during the quarter. Jacobs Levy Equity Management Inc. owned approximately 1.17% of ZimVie worth $5,277,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. Kennedy Capital Management LLC grew its position in shares of ZimVie by 8.8% during the first quarter. Kennedy Capital Management LLC now owns 240,686 shares of the company’s stock worth $3,969,000 after purchasing an additional 19,386 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in ZimVie by 6.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company’s stock valued at $356,000 after acquiring an additional 1,275 shares during the last quarter. Gabelli Funds LLC lifted its stake in ZimVie by 2.0% in the first quarter. Gabelli Funds LLC now owns 41,060 shares of the company’s stock worth $677,000 after purchasing an additional 800 shares during the last quarter. Teton Advisors Inc. boosted its holdings in ZimVie by 220.0% during the 1st quarter. Teton Advisors Inc. now owns 48,000 shares of the company’s stock valued at $792,000 after acquiring an additional 33,000 shares during the period. Finally, Gamco Investors INC. ET AL grew its holdings in shares of ZimVie by 6.0% in the first quarter. Gamco Investors INC. ET AL now owns 343,717 shares of the company’s stock worth $5,668,000 after purchasing an additional 19,459 shares during the last quarter. Institutional investors own 95.63% of the company’s stock.

ZimVie Stock Performance

Shares of ZimVie stock traded up $0.42 on Wednesday, reaching $21.40. 82,221 shares of the stock were exchanged, compared to its average volume of 345,467. ZimVie Inc. has a twelve month low of $6.52 and a twelve month high of $22.40. The business has a 50 day moving average price of $17.89 and a two-hundred day moving average price of $17.49. The company has a quick ratio of 2.23, a current ratio of 2.68 and a debt-to-equity ratio of 1.32. The firm has a market capitalization of $584.01 million, a price-to-earnings ratio of -1.50 and a beta of 2.17.

ZimVie (NASDAQ:ZIMV) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.08 earnings per share for the quarter. The company had revenue of $118.20 million for the quarter. ZimVie had a positive return on equity of 2.01% and a negative net margin of 56.31%. During the same period in the prior year, the business posted $0.25 earnings per share. Analysts anticipate that ZimVie Inc. will post 0.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Needham & Company LLC reiterated a “buy” rating and issued a $20.00 price target on shares of ZimVie in a report on Tuesday, June 25th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.